Skip to main content
SpringerLink
Log in

Ovarian Cancer Prevention

  • Chapter
Fundamentals of Cancer Prevention

  • 678 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Averette, H.E., M.F. Janicek, et al. (1995). "The National Cancer Data Base report on ovarian cancer. American College of Surgeons Commission on Cancer and the American Cancer Society." Cancer 76(6): 1096–1103.

    PubMed  Google Scholar 

  • Bai, W., B. Oliveros-Saunders, et al. (2000). "Estrogen stimulation of ovarian surface epithelial cell proliferation." In Vitro Cell Dev Biol Anim 36(10): 657–666.

    Article  PubMed  Google Scholar 

  • Barda, G., J. Menczer, et al. (2004). "Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study." Am J Obstet Gynecol 190(4): 1039–1045.

    Article  PubMed  Google Scholar 

  • Bray, F., A. H. Loos, et al. (2005). "Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953–2000." Int J Cancer 113(6): 977–990.

    Article  PubMed  Google Scholar 

  • Brewster, D. H., C.S. Thomson, et al. (2001). "Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies." BMJ 322(7290): 830–831.

    Article  PubMed  Google Scholar 

  • Buamah, P. (2000). "Benign conditions associated with raised serum CA-125 concentration." J Surg Oncol 75(4): 264–265.

    Article  PubMed  Google Scholar 

  • Canman, C. E., C.Y. Chen, et al. (1994). "DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis." Cold Spring Harb Symp Quant Biol 59: 277–286.

    PubMed  Google Scholar 

  • Claus, E.B., J.M. Schildkraut, et al. (1996). "The genetic attributable risk of breast and ovarian cancer." Cancer 77(11): 2318–2324.

    Article  PubMed  Google Scholar 

  • Cottreau, C.M., R.B. Ness, et al. (2000). "Physical activity and reduced risk of ovarian cancer." Obstet Gynecol 96(4): 609–614.

    Article  PubMed  Google Scholar 

  • Couzin, J. (2003). "Choices — and uncertainties — for women with BRCA mutations." Science 302(5645): 592.

    Article  PubMed  Google Scholar 

  • Cramer, D.W., E.R. Greenberg, et al. (2000). "A case-control study of galactose consumption and metabolism in relation to ovarian cancer." Cancer Epidemiol Biomarkers Prev 9(1): 95–101.

    PubMed  Google Scholar 

  • Cramer, D.W., B.L. Harlow, et al. (1998). "Over-the-counter analgesics and risk of ovarian cancer." Lancet 351(9096): 104–107.

    Article  PubMed  Google Scholar 

  • Cramer, D.W. and H. Xu (1995). "Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer." Ann Epidemiol 5(4): 310–314.

    Article  PubMed  Google Scholar 

  • Daly, M. and G.I. Obrams (1998). "Epidemiology and risk assessment for ovarian cancer." Semin Oncol 25(3): 255–264.

    PubMed  Google Scholar 

  • Daly, M. B. (1992). "The epidemiology of ovarian cancer." Hematol Oncol Clin North Am 6(4): 729–738.

    Google Scholar 

  • De Palo, G., U. Veronesi, et al. (1995). "Can fenretinide protect women against ovarian cancer?" J Natl Cancer Inst 87(2): 146–147.

    PubMed  Google Scholar 

  • De Rosa, V., M.L. Mangoni di Stefano, et al. (1995). "Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan." Eur J Gynaecol Oncol 16(2): 123–129.

    PubMed  Google Scholar 

  • Delia, D., A. Aiello, et al. (1993). "N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid." Cancer Res 53(24): 6036–6041.

    PubMed  Google Scholar 

  • DHHS (1996). "Ovarian Cancer: Screening, Treatment and Followup." NIH Consensus Statement 12(3): April 5–7.

    Google Scholar 

  • Drake, J.G. and J.L. Becker (2002). "Aspirin-induced inhibition of ovarian tumor cell growth." Obstet Gynecol 100(4): 677–682.

    Article  PubMed  Google Scholar 

  • Drew, S.V. (2001). "Oestrogen replacement therapy and ovarian cancer." Lancet 358(9296): 1910.

    Article  Google Scholar 

  • Edmondson, R.J. and J.M. Monaghan (2001). "The epidemiology of ovarian cancer." Int J Gynecol Cancer 11(6): 423–429.

    Article  PubMed  Google Scholar 

  • el-Bayoumy, K., P. Upadhyaya, et al. (1995). "Chemoprevention of cancer by organoselenium compounds." J Cell Biochem Suppl 22: 92–100.

    Article  PubMed  Google Scholar 

  • Fairfield, K.M., D.J. Hunter, et al. (2002). "Aspirin, other NSAIDs, and ovarian cancer risk (United States)." Cancer Causes Control 13(6): 535–542.

    Article  PubMed  Google Scholar 

  • Fairfield, K.M., W.C. Willett, et al. (2002). "Obesity, weight gain, and ovarian cancer." Obstet Gynecol 100(2): 288–296.

    Article  PubMed  Google Scholar 

  • Ferrandina, G., F.O. Ranelletti, et al. (2002). "Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer." Gynecol Oncol 85(2): 305–310.

    Article  PubMed  Google Scholar 

  • Flegal, K. M., M. D. Carroll, et al. (2002). "Prevalence and trends in obesity among US adults, 1999–2000." JAMA 288(14): 1723–1727.

    Article  PubMed  Google Scholar 

  • Formelli, F. and L. Cleris (1993). "Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity." Cancer Res 53(22): 5374–5376.

    PubMed  Google Scholar 

  • Gladstone, C.Q. (1994). Screening for ovarian cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa, Health Canada: 870–881.

    Google Scholar 

  • Gloeckler Ries, L.A., M.E. Reichman, et al. (2003). "Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program." Oncologist 8(6): 541–552.

    Article  PubMed  Google Scholar 

  • Goff, B.A., L.S. Mandel, et al. (2004). "Frequency of symptoms of ovarian cancer in women presenting to primary care clinics." JAMA 291(22): 2705–2712.

    Article  PubMed  Google Scholar 

  • Goodman, M.T., C.N. Correa, et al. (2003). "Stage at diagnosis of ovarian cancer in the United States, 1992–1997." Cancer 97(10 Suppl): 2648–2659.

    Article  PubMed  Google Scholar 

  • Hakama, M., U.H. Stenman, et al. (1996). "CA 125 as a screening test for ovarian cancer." J Med Screen 3(1): 40–42.

    PubMed  Google Scholar 

  • Hankinson, S.E., G.A. Colditz, et al. (1995). "A prospective study of reproductive factors and risk of epithelial ovarian cancer." Cancer 76(2): 284–290.

    PubMed  Google Scholar 

  • Hildreth, N.G., J.L. Kelsey, et al. (1981). "An epidemiologic study of epithelial carcinoma of the ovary." Am J Epidemiol 114(3): 398–405.

    PubMed  Google Scholar 

  • Holschneider, C.H. and J.S. Berek (2000). "Ovarian cancer: epidemiology, biology, and prognostic factors." Semin Surg Oncol 19(1): 3–10.

    Article  PubMed  Google Scholar 

  • Huncharek, M. and B. Kupelnick (2001). "Dietary fat intake and risk of epithelial ovarian cancer: a meta-analysis of 6,689 subjects from 8 observational studies." Nutr Cancer 40(2): 87–91.

    Article  PubMed  Google Scholar 

  • Jacobs, I. (1998). Overview-progress in screening for ovarian cancer. In: Ovarian Cancer. F. Sharp, A. Blackett, et al. (Eds.). Oxford, Isis Medical Media.

    Google Scholar 

  • Jemal, A., R.C. Tiwari, et al. (2004). "Cancer statistics, 2004." CA Cancer J Clin 54(1): 8–29.

    PubMed  Google Scholar 

  • John, E.M., A.S. Whittemore, et al. (1993). "Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group." J Natl Cancer Inst 85(2): 142–147.

    PubMed  Google Scholar 

  • Katchy, K.C. and N.D. Briggs (1992). "Clinical and pathological features of ovarian tumours in Rivers state of Nigeria." East Afr Med J 69(8): 456–459.

    PubMed  Google Scholar 

  • Koifman, S. and R. Jorge Koifman (2001). "Breast cancer mortality among Ashkenazi Jewish women in Sao Paulo and Porto Alegre, Brazil." Breast Cancer Res 3(4): 270–275.

    Article  PubMed  Google Scholar 

  • Kumle, M., E. Alsaker, et al. (2003). "[Use of oral contraceptives and risk of cancer, a cohort study]." Tidsskr Nor Laegeforen 123(12): 1653–1656.

    PubMed  Google Scholar 

  • Lacey, J.V., Jr., P.J. Mink, et al. (2002). "Menopausal hormone replacement therapy and risk of ovarian cancer." JAMA 288(3): 334–341.

    Article  PubMed  Google Scholar 

  • Leeper, K., R. Garcia, et al. (2002). "Pathologic findings in prophylactic oophorectomy specimens in high-risk women." Gynecol Oncol 87(1): 52–56.

    Article  PubMed  Google Scholar 

  • Lipsett, M.B. (1979). "Interaction of drugs, hormones, and nutrition in the causes of cancer." Cancer 43(5 Suppl): 1967–1981.

    PubMed  Google Scholar 

  • Malik, I.A. (2002). "A prospective study of clinico-pathological features of epithelial ovarian cancer in Pakistan." J Pak Med Assoc 52(4): 155–158.

    PubMed  Google Scholar 

  • Mansfield, C.M. (1993). "A review of the etiology of breast cancer." J Natl Med Assoc 85(3): 217–221.

    PubMed  Google Scholar 

  • McGuire, V., L. Herrinton, et al. (2002). "Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization." Epidemiology 13(2): 231–234.

    Article  PubMed  Google Scholar 

  • Morice, P., P. Pautier, et al. (1999). "Laparoscopic prophylactic oophorectomy in women with inherited risk of ovarian cancer." Eur J Gynaecol Oncol 20(3): 202–204.

    PubMed  Google Scholar 

  • Murdoch, W.J. and A.C. McDonnel (2002). "Roles of the ovarian surface epithelium in ovula-tion and carcinogenesis." Reproduction 123(6): 743–750.

    Article  PubMed  Google Scholar 

  • Narod, S.A., H. Risch, et al. (1998). "Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group." N Engl J Med 339(7): 424–428.

    Article  PubMed  Google Scholar 

  • Negri, E., S. Franceschi, et al. (1991). "Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer." Int J Cancer 49(1): 50–56.

    PubMed  Google Scholar 

  • Ness, R.B., D.W. Cramer, et al. (2002). "Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies." Am J Epidemiol 155(3): 217–224.

    Article  PubMed  Google Scholar 

  • Ness, R.B., J.A. Grisso, et al. (2000). "Risk of ovarian cancer in relation to estrogen and pro-gestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions." Am J Epidemiol 152(3): 233–241.

    Article  PubMed  Google Scholar 

  • Nguyen, H.N., H.E. Averette, et al. (1994). "Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention." Cancer 74(2): 545–555.

    PubMed  Google Scholar 

  • Piver, M.S., M.F. Jishi, et al. (1993). "Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry." Cancer 71(9): 2751–2755.

    PubMed  Google Scholar 

  • Polednak, A.P. (1992). "Cancer incidence in the Puerto Rican-born population of Connecticut." Cancer 70(5): 1172–1176.

    PubMed  Google Scholar 

  • Ponzoni, M., P. Bocca, et al. (1995). "Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation." Cancer Res 55(4): 853–861.

    PubMed  Google Scholar 

  • Rebbeck, T.R. (2000). "Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers." JClin Oncol 18(21 Suppl): 100S–103S.

    Google Scholar 

  • Rebbeck, T.R., A.M. Levin, et al. (1999). "Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers." J Natl Cancer Inst 91(17): 1475–1479.

    Article  PubMed  Google Scholar 

  • Ries, L.A.G., M.P. Eisner, et al. (2004). SEER Cancer Statistics Review, 1995–2001. Bethesda, MD, National Cancer Institute.

    Google Scholar 

  • Riman, T., P.W. Dickman, et al. (2002). "Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study." Am J Epidemiol 156(4): 363–373.

    Article  PubMed  Google Scholar 

  • Risch, H.A., L.D. Marrett, et al. (1994). "Parity, contraception, infertility, and the risk of epithelial ovarian cancer." Am J Epidemiol 140(7): 585–597.

    PubMed  Google Scholar 

  • Rodriguez, C, A.V. Patel, et al. (2001). "Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women." Jama 285(11): 1460–1465.

    Article  PubMed  Google Scholar 

  • Rodriguez, G.C., D. K. Walmer, et al. (1998). "Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?" J Soc Gynecol Investig 5(5): 271–276.

    Article  PubMed  Google Scholar 

  • Rodriguez-Burford, C, M.N. Barnes, et al. (2002). "Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as che-mopreventive agents." Clin Cancer Res 8(1): 202–209.

    PubMed  Google Scholar 

  • Rosenblatt, K.A. and D.B. Thomas (1996). "Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives." Cancer Epidemiol Biomarkers Prev 5(11): 933–935.

    PubMed  Google Scholar 

  • Rosenthal, A. and I. Jacobs (1998). "Ovarian cancer screening." Semin Oncol 25(3): 315–325.

    PubMed  Google Scholar 

  • Schildkraut, J.M. and W.D. Thompson (1988). "Familial ovarian cancer: a population-based case-control study." Am J Epidemiol 128(3): 456–466.

    PubMed  Google Scholar 

  • Sellers, T.A., S. M. Gapstur, et al. (1993). "Association of body fat distribution and family histories of breast and ovarian cancer with risk of postmenopausal breast cancer." Am J Epidemiol 138(10): 799–803.

    PubMed  Google Scholar 

  • Siskind, V., A. Green, et al. (2000). "Beyond ovulation: oral contraceptives and epithelial ovarian cancer." Epidemiology 11(2): 106–110.

    Article  PubMed  Google Scholar 

  • Sit, A.S., F. Modugno, et al. (2002). "Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma." Gynecol Oncol 86(2): 118–123.

    Article  PubMed  Google Scholar 

  • Stanford, J.L. (1991). "Oral contraceptives and neoplasia of the ovary." Contraception 43(6): 543–556.

    Article  PubMed  Google Scholar 

  • Steinberg, K.K., J.M. Pernarelli, et al. (1998). "Increased risk for familial ovarian cancer among Jewish women: a population-based case-control study." Genet Epidemiol 15(1): 51–59.

    Article  PubMed  Google Scholar 

  • Supino, R., M. Crosti, et al. (1996). "Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression." Int J Cancer 65(4): 491–497.

    Article  PubMed  Google Scholar 

  • Tavani, A., S. Gallus, et al. (2000). "Aspirin and ovarian cancer: an Italian case-control study." Ann Oncol 11(9): 1171–1173.

    Article  PubMed  Google Scholar 

  • Thompson, H.J., C. Jiang, et al. (1997). "Sulfone metabolite of sulindac inhibits mammary carcinogenesis." Cancer Res 57(2): 267–271.

    PubMed  Google Scholar 

  • Thompson, H.J., A. Wilson, et al. (1994). "Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line." Carcinogenesis 15(2): 183–186.

    PubMed  Google Scholar 

  • Tobacman, J.K., M. H. Greene, et al. (1982). "Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families." Lancet 2(8302): 795–797.

    Article  PubMed  Google Scholar 

  • Toma, S., L. Isnardi, et al. (1997). "Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction." Int J Cancer 70(5): 619–627.

    Article  PubMed  Google Scholar 

  • Vachon, C.M., P.J. Mink, et al. (2002). "Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women." Epidemiology 13(1): 66–71.

    Article  PubMed  Google Scholar 

  • van der Burg, M.E., F.B. Lammes, et al. (1993). "The role of CA 125 and conventional examinations in diagnosing progressive carcinoma of the ovary." Surg Gynecol Obstet 176(4): 310–314.

    PubMed  Google Scholar 

  • van Nagell, J.R., Jr., P.D. DePriest, et al. (2000). "The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer." Gynecol Oncol 77(3): 350–356.

    Article  PubMed  Google Scholar 

  • Walker, G.R., J.J. Schlesselman, et al. (2002). "Family history of cancer, oral contraceptive use, and ovarian cancer risk." Am J Obstet Gynecol 186(1): 8–14.

    Article  PubMed  Google Scholar 

  • Whittemore, A.S., R. Harris, et al. (1992). "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group." Am J Epidemiol 136(10): 1212–1220.

    PubMed  Google Scholar 

  • Wu, M.L., A.S. Whittemore, et al. (1988). "Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use." Am J Epidemiol 128(6): 1216–1227.

    PubMed  Google Scholar 

  • Yancik, R. (1993). "Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality." Cancer 71(2 Suppl): 517–523.

    PubMed  Google Scholar 

  • Yawn, B. P., B.A. Barrette, et al. (2004). "Ovarian cancer: the neglected diagnosis." Mayo Clin Proc 79(10): 1277–1282.

    PubMed  Google Scholar 

  • Zhang, M., C.W. Binns, et al. (2002). "Tea consumption and ovarian cancer risk: a case-control study in China." Cancer Epidemiol Biomarkers Prev 11(8): 713–718.

    PubMed  Google Scholar 

  • Zhang, M., Z.Y. Yang, et al. (2002). "Diet and ovarian cancer risk: a case-control study in China." Br J Cancer 86(5): 712–717.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine, University of Arizona, Tucson, AZ, 85724

    Kathryn Coe, Ana Maria Lopez & Lisa M. Hess

Authors
  1. Kathryn Coe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Maria Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lisa M. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Prevention and Control, Arizona Cancer Center, 1515 N. Campbell Avenue, PO Box 245024, Tuscon, AZ, 85724

    David S. Alberts  & Lisa M. Hess  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Coe, K., Lopez, A.M., Hess, L.M. (2005). Ovarian Cancer Prevention. In: Alberts, D.S., Hess, L.M. (eds) Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26337-3_15

Download citation

  • DOI: https://doi.org/10.1007/3-540-26337-3_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24212-3

  • Online ISBN: 978-3-540-26337-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation